HOME >> BIOLOGY >> NEWS
Novel Viral Vaccine Protects Aids In Animal Model

Research Triangle Park, N.C., Nov. 11, 1998 -- BioStratum Incorporated announced today that its proprietary gene-attenuated virus vaccine candidates prevent the development of AIDS in monkeys. The report, published in the November Journal of Virology, documents the efficacy of two gene-attenuated virus vaccines that protect macaque monkeys against exposure to an HIV-1- based virus that produces AIDS. Opendra ("Bill") Narayan, Ph.D., D.V.M., director of the Marion Merrell Dow Laboratory of Viral Pathogenesis at the University of Kansas Medical Center, conducted the study.

BioStratum also announced today the formation of a new subsidiary, TheraVax Incorporated, to expand current development efforts for a novel treatment for HIV infections that consists of a viral vaccine administered in combination with anti-HIV drugs. The goal of this new therapy will be to reduce or eliminate the need for continued drug cocktail therapy. All HIV-related technology currently licensed from the University of Kansas Medical Center to BioStratum, including a proprietary HIV-1-based AIDS animal model and the candidate gene-attenuated virus vaccines, will be transferred to TheraVax for development and commercialization.

"With more people living with HIV infection, the need is great for an affordable, effective treatment such as a therapeutic vaccine that does not have the harmful side effects of the current anti-HIV drug therapies," says Archie Prestayko, Ph.D., president and chief executive officer of BioStratum.

In the Journal of Virology study, Narayan and his colleagues tested the protective effects of the viral vaccines by exposing the immunized monkeys to a highly pathogenic hybrid virus named KU-SHIV-1, which Narayan developed three years ago. KU-SHIV-1's inner structure is derived from SIV (simian immunodeficiency virus) and the virus' outer surface, or envelope, is derived from HIV-1 (human immunodeficiency virus). The compos
'"/>

Contact: Anjani Shah, Ph.D.
a.shah@noonanrusso.com
212-696-4455 x.340
Noonan/Russo Communications
11-Nov-1998


Page: 1 2 3

Related biology news :

1. Novel IBD therapeutic approaches reported from Washington Univ., Barcelona, LSU at APS meeting
2. Novel therapeutic bortezomib moves to phase II trial in lung cancer patients
3. Novel approaches to current cellular therapies continue progress toward disease prevention
4. Novel therapies show promise against myeloid leukemia
5. Novel sensors help clear the air
6. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
7. Novel proteins designed that block inflammation regulator associated with rheumatoid arthritis
8. Novel therapeutic target identified in fight against Rheumatoid Arthritis
9. Novel bacterium detoxifies chlorinated pollutants
10. Novel flu vaccine shows promise in mice
11. Novel gene therapy on the horizon, says Brenner Childrens Hospital pediatrician

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/27/2019)... ... ... Though the forecast for the Thanksgiving holiday might look a bit grim, ... the roads and the skies. It’s a new personal recipe organizer app called MINE ... simple design, mouth-watering pictures of food, an optional social component and an easy-to-navigate recipe ...
(Date:11/22/2019)... ... 21, 2019 , ... The inventors of a new and ... major step forward with that therapy, known as SurVaxM. MimiVax LLC principals Robert ... from Roswell Park in 2012, has entered into a China-exclusive licensing agreement for ...
(Date:11/19/2019)... (PRWEB) , ... November 19, 2019 , ... The inaugural ... Times Square in New York City. The one-day event will be chaired by Dr ... of leaders in the space. , “We are witnessing significant innovation in cell ...
Breaking Biology News(10 mins):
(Date:12/18/2019)... , ... December 17, 2019 , ... ... is pleased to announce that it has hired Dr. Alia Orbin, Ph.D., ... Orbin is experienced in the preparation, filing and prosecution of patent applications related ...
(Date:12/4/2019)... ... 03, 2019 , ... A new survey by MedReps ( http://www.medreps.com ), a ... overall best medical sales companies to work for in 2020. , The ... professionals from the MedReps community to identify which medical sales companies are currently the ...
(Date:12/4/2019)... Indiana (PRWEB) , ... December 04, 2019 , ... ... strategy to further enhance dissolution and stabilize amorphous materials. Additionally, their PDF Synchrotron ... enhance the ability to describe these compositions both in regulatory and patent applications.  ...
(Date:11/22/2019)... (PRWEB) , ... November 22, ... ... chain engineering firm, hosted a live webinar covering a step-by-step cold chain ... antibodies, antibody-drug conjugates, and cell therapies. Targeting complex cold chain biopharmaceutical industry ...
Breaking Biology Technology:
Cached News: